{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:04Z","timestamp":1792112224650,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3626,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Boehringer Ingelheim Vetmedica GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dilated cardiomyopathy (DCM) is a common cause of morbidity and mortality in the Irish Wolfhound (IW). However, the benefit of medical treatment in IW dogs with preclinical DCM, atrial fibrillation (AF), or both has not been demonstrated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Compare the time to develop congestive heart failure (CHF) or sudden death in IW dogs with preclinical DCM, AF, or both receiving monotherapy with pimobendan, methyldigoxin, or benazepril hydrochloride.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Seventy-five client-owned IW dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Irish Wolfhound dogs were prospectively randomized to receive pimobendan (Vetmedin\u00ae)a, benazepril HCl (Fortekor\u00ae)b, or methyldigoxin (Lanitop\u00ae)c monotherapy in a 1:1:1 ratio in a blinded clinical trial. The prospectively defined composite primary endpoint was onset of CHF or sudden death. To assure stringent evaluation of treatment effect, data from dogs complying with the study protocol were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-six IW fulfilling the study protocol included 39 males, 27 females; median (interquartile range) age, 4.0 years (3.0\u20135.0 years) and weight, 70.0 kg (63.0\u201375.0 kg). Primary endpoint was reached in 5 of 23 (21.7%) IW receiving pimobendan, 11 of 22 (50.0%) receiving benazepril HCl, and 9 of 21 (42.9%) receiving methyldigoxin. Median time to primary endpoint was significantly longer for pimobendan (1,991 days; 65.4 months) compared to methyldigoxin (1,263 days; 41.5 months; P = .031) or benazepril HCl-(997 days; 32.8 months; P = .008) treated dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>In IW dogs with preclinical DCM, AF or both, pimobendan monotherapy significantly prolonged time to onset of CHF or sudden death than did monotherapy with benazepril HCl or methyldigoxin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.13914","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T03:04:02Z","timestamp":1456974242000},"page":"553-559","source":"Crossref","is-referenced-by-count":33,"title":["Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy"],"prefix":"10.1093","volume":"30","author":[{"given":"A.C.","family":"Vollmar","sequence":"first","affiliation":[{"name":"Small Animal Clinic (Wissen and Bonn Germany) , New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Fox","sequence":"additional","affiliation":[{"name":"The Animal Medical Center , New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"2026020304504952600_jvim13914-bib-0001","first-page":"582","volume-title":"Textbook of Canine and Feline Cardiology Principles and Practice","author":"Sisson","year":"1999","edition":"2nd ed"},{"key":"2026020304504952600_jvim13914-bib-0002","first-page":"995","volume-title":"Textbook of Veterinary Internal Medicine. Diseases of the Dog and Cat","author":"Sisson","year":"1995","edition":"4th ed"},{"key":"2026020304504952600_jvim13914-bib-0003","first-page":"647","volume-title":"Current Veterinary Therapy XI","author":"Buchanan","year":"1992"},{"key":"2026020304504952600_jvim13914-bib-0004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/vr.129.21.470","article-title":"An electrocardiographic survey of cardiac rhythm in Irish wolfhounds","volume":"129","author":"Brownlie","year":"1991","journal-title":"Vet Rec"},{"key":"2026020304504952600_jvim13914-bib-0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5326\/15473317-36-2-125","article-title":"The prevalence of cardiomyopathy in the Irish wolfhound: A clinical study of 500 dogs","volume":"36","author":"Vollmar","year":"2000","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304504952600_jvim13914-bib-0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jvc.2005.07.002","article-title":"Atrial fibrillation in dogs with and without structural or functional cardiac disease: A retrospective study of 109 cases","volume":"7","author":"Menaut","year":"2005","journal-title":"J Vet Cardiol"},{"key":"2026020304504952600_jvim13914-bib-0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1748-5827.1999.tb03102.x","article-title":"Observations on the development of congestive heart failure in Irish wolfhounds with dilated cardiomyopathy","volume":"40","author":"Brownlie","year":"1999","journal-title":"J Small Anim Pract"},{"key":"2026020304504952600_jvim13914-bib-0008","first-page":"151","article-title":"Epidemiology of atrial fibrillation in the dog","volume":"6","author":"Westling","year":"2008","journal-title":"Int J Appl Res Vet Med"},{"key":"2026020304504952600_jvim13914-bib-0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026020304504952600_jvim13914-bib-0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.hlc.2011.07.008","article-title":"Guidelines for the diagnosis and management of familial dilated cardiomyopathy","volume":"20","author":"Fatkin","year":"2011","journal-title":"Heart Lung Circ"},{"key":"2026020304504952600_jvim13914-bib-0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjcard.2008.06.068","article-title":"Effectiveness of digoxin in reducing one-year mortality in chronic Heart failure in the digitalis investigation group trial","volume":"103","author":"Ahmed","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026020304504952600_jvim13914-bib-0012","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.231.7.1061","article-title":"Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency","volume":"231","author":"Atkins","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304504952600_jvim13914-bib-0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.2002.tb01610.x","article-title":"Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation","volume":"16","author":"Kvart","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1751-0813.1995.tb06187.x","article-title":"Preferences of veterinarians for drugs to treat heart disease in dogs and cats","volume":"72","author":"Church","year":"1995","journal-title":"Aust Vet J"},{"key":"2026020304504952600_jvim13914-bib-0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/tvjl.2001.0616","article-title":"Canine idiopathic dilated cardiomyopathy Part II: Pathophysiology and therapy","volume":"162","author":"Borgarelli","year":"2001","journal-title":"Vet J"},{"key":"2026020304504952600_jvim13914-bib-0016","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/vr.102818","article-title":"Variation in the management of congestive cardiac failure in dogs","volume":"176","author":"Davies","year":"2015","journal-title":"Vet Rec"},{"key":"2026020304504952600_jvim13914-bib-0017","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/01.CIR.89.6.2852","article-title":"Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction","volume":"89","author":"Sabbah","year":"1994","journal-title":"Circulation"},{"key":"2026020304504952600_jvim13914-bib-0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2460\/javma.1985.186.02.162","article-title":"Efficacy of digoxin administration in dogs with idiopathic congestive cardiomyopathy","volume":"186","author":"Kittleson","year":"1985","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304504952600_jvim13914-bib-0019","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cvsm.2010.04.003","article-title":"Current use of pimobendan in canine patients with heart disease","volume":"40","author":"Boswood","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020304504952600_jvim13914-bib-0021","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1939-1676.2012.01026.x","article-title":"Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman pinschers with preclinical dilated cardiomyopathy (the PROTECT Study)","volume":"26","author":"Summerfield","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0022","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1939-1676.2009.0346.x","article-title":"Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers","volume":"23","author":"O'Grady","year":"2009","journal-title":"J Vet Int Med"},{"key":"2026020304504952600_jvim13914-bib-0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0024","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5326\/15473317-35-4-279","article-title":"Use of echocardiography in the diagnosis of dilated cardiomyopathy in Irish wolfhounds","volume":"35","author":"Vollmar","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304504952600_jvim13914-bib-0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5326\/15473317-35-4-271","article-title":"Echocardiographic measurements in the Irish wolfhound: Reference values for the breed","volume":"35","author":"Vollmar","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304504952600_jvim13914-bib-0026","volume-title":"European Medicines Agency\/Committee for Medicinal Products for Veterinary Use\/Efficacy Working Party\/81976\/2010: Guideline on statistical principles for clinical trials for veterinary medicinal products (pharmaceuticals)"},{"key":"2026020304504952600_jvim13914-bib-0027","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/jvim.12217","article-title":"Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure","volume":"27","author":"H\u00e4ggstr\u00f6m","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0028","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0029","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/0420249","article-title":"Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs","volume":"42","author":"Lombard","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304504952600_jvim13914-bib-0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1939-1676.2002.tb02366.x","article-title":"A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy","volume":"16","author":"Fuentes","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0031","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1939-1676.2008.0116.x","article-title":"Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy","volume":"22","author":"O'Grady","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020304504952600_jvim13914-bib-0032","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00495953","article-title":"UD-CG 115-a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle","volume":"325","author":"Honerj\u00e4ger","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2026020304504952600_jvim13914-bib-0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(94)90426-X","article-title":"Effects of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels","volume":"265","author":"Fujimoto","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"2026020304504952600_jvim13914-bib-0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","article-title":"The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long term clinical trial","volume":"1","author":"BENCH Study Group","year":"1999","journal-title":"J Vet Cardiol"},{"key":"2026020304504952600_jvim13914-bib-0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0034-5288(95)90055-1","article-title":"Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy","volume":"59","author":"Koch","year":"1995","journal-title":"Res Vet Sci"},{"key":"2026020304504952600_jvim13914-bib-0036","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"Am J Vet Res"},{"key":"2026020304504952600_jvim13914-bib-0037","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/CIRCULATIONAHA.110.968057","article-title":"Adverse bioenergetics consequences of Na+-CA2+ exchanger-mediated Ca2+ influx in cardiac myocytes","volume":"122","author":"Kohlhaas","year":"2010","journal-title":"Circulation"},{"key":"2026020304504952600_jvim13914-bib-0038","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2026020304504952600_jvim13914-bib-0039","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"Ouyang","year":"2015","journal-title":"Am J Cardiol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.13914","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.13914","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.13914","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/2\/553\/66693365\/jvim13914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/2\/553\/66693365\/jvim13914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:51:00Z","timestamp":1770112260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/30\/2\/553\/8452834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.13914","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,3]]},"published":{"date-parts":[[2016,3,1]]}}}